Curcumin relieves oxaliplatin‐induced neuropathic pain via reducing inflammation and activating antioxidant response
Cell Biology International · 2024
DOI: 10.1002/cbin.12153 ↗At a glance
Journal article in Cell Biology International, 2024. Written by Meng-Wei Zhang and 7 co-authors. Institution: School of Stomatology and Ophthalmology, School of Pharmacy, Hubei University of Science and Technology, Xianning, Hubei, China. Major MEDLINE topics: Oxaliplatin, Neuralgia, Curcumin, Antioxidants. Cited 24 times so far (Crossref); 58 references. Funded by: Hubei Provincial Natural Science Foundation, Hubei University of Science and Technology Program.
Abstract (original language)
Oxaliplatin (OXA) has shown high effectiveness in the treatment of cancers, but its anticancer clinical effects often induce neurotoxicity leading to neuropathic pain. Oxidative damage and NLRP3 inflammasome play important roles in neuropathic pain development. Here, neuropathic pain mouse model was constructed by continuous intraperitoneal injection of OXA. OXA administration induced mechanical pain, spontaneous pain, thermal hyperalgesia and motor disability in mice. The spinal cord tissues of OXA mice exhibited the suppressed antioxidative response, the activated NLRP3 inflammasome mediated inflammatory responses, and the increased GSK‐3β activity. Next, we injected curcumin (CUR) intraperitoneally in OXA mice for seven consecutive days. CUR‐treated mice showed increased mechanical pain thresholds, reduced number of spontaneous flinches, increased paw withdrawal latency, and restored latency to fall. While in the spinal cord, CUR treatment inhibited the NLRP3 inflammasome mediated inflammatory response, increased Nrf2/GPX4‐mediated antioxidant responses, and decreased mitochondrial oxidative generation. Additionally, CUR combined with GSK‐3β through four covalent bonds and reduced GSK‐3β activity. In conclusion, our findings suggest that CUR treatment inhibits GSK‐3β activation, increases Nrf2 mediated antioxidant responses, inhibits oxidative damage and inflammatory reaction, and alleviates OXA‐induced neuropathic pain.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Stomatology and Ophthalmology, School of Pharmacy, Hubei University of Science and Technology, Xianning, Hubei, China.
- Xianning Central Hospital, First Affiliated Hospital of Hubei University of Science and Technology, Xianning, Hubei, China.
- Hubei Key Laboratory of Diabetes and Angiopathy, School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, China.
Funding
- Hubei Provincial Natural Science Foundation
- Hubei University of Science and Technology Program
Cite
APA
Zhang, M. W., Sun, X., Xu, Y. W., Meng, W., Tang, Q., Gao, H., Liu, L., & Chen, S. H. (2024). Curcumin relieves oxaliplatin‐induced neuropathic pain via reducing inflammation and activating antioxidant response. Cell Biology International. https://doi.org/10.1002/cbin.12153
Vancouver
Zhang MW, Sun X, Xu YW, Meng W, Tang Q, Gao H, et al. Curcumin relieves oxaliplatin‐induced neuropathic pain via reducing inflammation and activating antioxidant response. Cell Biology International. 2024. doi:10.1002/cbin.12153
BibTeX
@article{Zhang2024,
author = {Zhang, Meng-Wei and Sun, Xu and Xu, Yi-Wen and Meng, Wei and Tang, Qiong and Gao, Hui and Liu, Ling and Chen, Shao-Hui},
title = {Curcumin relieves oxaliplatin‐induced neuropathic pain via reducing inflammation and activating antioxidant response},
journal = {Cell Biology International},
year = {2024},
doi = {10.1002/cbin.12153}
}
EUVIMED